| 12023385 |
Tunable endogenous protein degradation with heterobifunctional compounds |
Dennis Buckley, Georg Winter, Andrew J. Phillips, Timothy Heffernan, Justin Roberts +1 more |
2024-07-02 |
| 11617750 |
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof |
John H. van Duzer, Ralph Mazitschek, Walter Ogier, Guoxiang Huang, Dejian Xie +1 more |
2023-04-04 |
| 11583586 |
Methods to induce targeted protein degradation through bifunctional molecules |
Dennis Buckley, Georg Winter |
2023-02-21 |
| 11311609 |
Regulating chimeric antigen receptors |
Justin Roberts, Behnam Nabet, Georg Winter, Andrew J. Phillips, Timothy Heffernan +1 more |
2022-04-26 |
| 11293023 |
Tunable endogenous protein degradation |
Dennis Buckley, Georg Winter, Andrew J. Phillips, Timothy Heffernan, Justin Roberts +1 more |
2022-04-05 |
| 11285218 |
Degradation of bromodomain-containing protein 9 (BRD9) by conjugation of BRD9 inhibitors with E3 ligase ligand and methods of use |
Dennis Buckley, David Ian Remillard |
2022-03-29 |
| 11059801 |
Methods to induce targeted protein degradation through bifunctional molecules |
Dennis Buckley, Georg Winter |
2021-07-13 |
| 11046954 |
Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses |
Justin Roberts, Behnam Nabet, Georg Winter, Andrew J. Phillips, Timothy Heffernan +1 more |
2021-06-29 |
| 10925868 |
Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use |
Nathanael S. Gray, Li Tan, Hai-Tsang Huang, Dennis Buckley, Georg Winter +1 more |
2021-02-23 |
| 10899768 |
Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use |
Dennis Buckley, Mette Ishoey ROSENBAUM, Georg Winter |
2021-01-26 |
| 10849980 |
Methods to induce targeted protein degradation through bifunctional molecules |
Dennis Buckley, Georg Winter |
2020-12-01 |
| 10702504 |
Degradation of tripartite motif-containing protein 24 (TRIM24) by conjugation of TRIM24 inhibitors with E3 ligase ligand and methods of use |
Dennis Buckley, Lara Nicole Gechijian |
2020-07-07 |
| 10172821 |
Histone deacetylase inhibitors |
Ralph Mazitschek |
2019-01-08 |
| 10172905 |
Treatment of protein degradation disorders |
Kenneth C. Anderson, Edward Franklin Greenberg, Teru Hideshima, Nicholas Paul Kwiatkowski, Ralph Mazitschek +3 more |
2019-01-08 |
| 10087149 |
Selective histone deacetylase 8 inhibitors |
Aaron Beaty BEELER, John A. Porco, Jr., Oscar Ingham |
2018-10-02 |
| 10071129 |
Method for identifying bromodomain inhibitors |
Richard A. Young, Peter B. Rahl |
2018-09-11 |
| 10059657 |
Class-and isoform-specific HDAC inhibitors and uses thereof |
Ralph Mazitschek |
2018-08-28 |
| 9724321 |
Histone deacetylase inhibitors |
Ralph Mazitschek |
2017-08-08 |
| 9572854 |
Treatment of protein degradation disorders |
Kenneth C. Anderson, Edward Franklin Greenberg, Teru Hideshima, Nicholas Paul Kwiatkowski, Ralph Mazitschek +3 more |
2017-02-21 |
| 9567301 |
Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors |
Michael R. McKeown, Peter B. Rahl, Richard A. Young, Jason J. Marineau |
2017-02-14 |
| 9540317 |
Class- and isoform-specific HDAC inhibitors and uses thereof |
Ralph Mazitschek |
2017-01-10 |
| 9434686 |
Deacetylase inhibitors and uses thereof |
Weiping Tang, Stuart L. Schreiber |
2016-09-06 |
| 9199923 |
Histone deacetylase inhibitors |
Ralph Mazitschek |
2015-12-01 |
| 8999289 |
Treatment of protein degradation disorders |
Kenneth C. Anderson, Edward Franklin Greenberg, Teru Hideshima, Nicholas Paul Kwiatkowski, Ralph Mazitschek +3 more |
2015-04-07 |
| 8754237 |
Bifunctional histone deacetylase inhibitors |
Ralph Mazitschek, Weiping Tang, Stuart L. Schreiber |
2014-06-17 |